Clinical trial
Diagnostic Study of Gene Alterations in Patients With Acute Myeloid Leukemia
NCT00003931 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00003931 |
|---|---|
| Title | Diagnostic Study of Gene Alterations in Patients With Acute Myeloid Leukemia |
| Official title | Assessment of the Partial Tandem Duplication of ALL1 (MLL) in Patients With Acute Myeloid Leukemia- A CALGB Leukemia Tissue Bank Project |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Leukemia |
| Intervention type | Genetic |
| Interventions | reverse transcriptase-polymerase chain reaction |
| Enrollment | 9,769 |
| Start date | Feb 1, 1999 |
| Primary completion | Jun 1, 2006 |
| Completion | Jun 1, 2006 |
| First posted | Aug 20, 2003 |
| Last update posted | Jul 4, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: